Since growth-promoting actions and angiogenesis play a pivotal role in wound healing, selective cyclooxygenase-2 inhibitors may suppress these activities in gastric ulcer tissues and delay the healing process. The gene discussed is PTGS2; the disease is gastric ulcer.